Patent · US Expired

Vaccines containing ribavirin and methods of use thereof

US6858590B2 · kind B2 · utility

19Cited by

63References

14Claims

0Family size

Assignee

TRIPEP AB · SE

Inventors

Matti Sallberg · Stockholm, SE
Catharina Hultgren · Stockholm, SE

Key dates

Filing date	Aug 15, 2001
Grant date	Feb 22, 2005
Priority date	—
Expiry date	Nov 1, 2021

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A90/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions and methods for enhancing the effect of vaccines in animals, such as domestic, sport, or pet species, and humans are disclosed. More particularly, vaccine compositions comprising ribavirin and an antigen, preferably an antigen that has an epitope present in Hepatitis C virus (HCV), are disclosed for use in treating and preventing disease, preferably HCV infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.